Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.7%

17 terminated/withdrawn out of 159 trials

Success Rate

86.8%

+0.3% vs industry average

Late-Stage Pipeline

28%

44 trials in Phase 3/4

Results Transparency

16%

18 of 112 completed trials have results

Key Signals

12 recruiting18 with results10 terminated7 withdrawn

Enrollment Performance

Analytics

N/A

38(41.8%)

Phase 3

28(30.8%)

Phase 4

16(17.6%)

Phase 2

6(6.6%)

Phase 1

3(3.3%)

91Total

N/A(38)

Phase 3(28)

Phase 4(16)

Phase 2(6)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (159)

Showing 20 of 159 trials

NCT06599970Active Not Recruiting

Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility

Role: lead

NCT07499739Phase 4Not Yet Recruiting

Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo

Role: lead

NCT07174648Not Yet Recruiting

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

Role: lead

NCT07487350Recruiting

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Role: lead

NCT05313139Completed

Surveillance of Vaccine-induced Immunity Against Ebola in Previously Vaccinated Health Care Workers

Role: lead

NCT05879965Recruiting

Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk

Role: lead

NCT06579885Completed

Ocular Complications of Mpox in the Democratic Republic Congo

Role: lead

NCT06064591Completed

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

Role: lead

NCT07463040Phase 3Not Yet Recruiting

Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)

Role: lead

NCT07455318Phase 3Not Yet Recruiting

Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.

Role: lead

NCT07387341Not ApplicableNot Yet Recruiting

Long-acting Spatial Emanators / Repellents (LASER)

Role: collaborator

NCT07342829Not Yet Recruiting

Prospective Follow-up After MVA-BN Booster Vaccination

Role: lead

NCT05879224Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

Role: collaborator

NCT07345286Recruiting

Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC

Role: lead

NCT05722184Completed

Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa

Role: lead

NCT05378880Not ApplicableCompleted

Optimising Community Antibiotic Use and Infection Control With Behavioural Interventions in Burkina Faso and DR Congo

Role: lead

NCT04666311Completed

Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis

Role: collaborator

NCT05526885Not ApplicableCompleted

Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa

Role: collaborator

NCT06839989Phase 2Recruiting

An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC

Role: lead

NCT06981442Not ApplicableRecruiting

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Role: lead